Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...

And this presents a unique challenge because we don't have any diagnostic tests that we can say, hey, you definitively have long COVID. It really requires a long and extensive and rather expensive ...

For many, COVID-19 has become a distant memory. But for Patricia Hill, it’s an ongoing battle—one that has reshaped her life in ways she never imagined.

Everyone who gets a COVID-19 infection is at potential risk for developing long COVID. It’s important to emphasize, especially as we are still living with this virus, that there’s a new risk of ...

When patients feel heard and believed, they become more open to psychological tools—not as a cure, but as a way to cope with uncertainty, identity disruption, and the daily challenges of Long Covid.

Long Covid is known to cause over 200 different symptoms in nearly a dozen organ systems, including those of the heart, ... The challenge now is finding one or more biomarkers — genes, ...

Long COVID by contrast has emerged among working-age adults, Ikramuddin said, ... Doctors have reported challenges in diagnosing and treating long COVID, ...

Q&A with a researcher fighting long COVID and searching for ... she took time to discuss the challenges experienced daily by those who continue to experience severe symptoms months or even ...

Long COVID linked to lasting physical and mental health challenges, study finds—vaccination offers protective benefits. Study: Differences in Long COVID severity by duration of illness, symptom ...

ALBANY – As with the 1918 Spanish flu, the most lethal pandemic in recorded world history, the 2020 Covid-19 health crisis promises to bring sweeping changes and improvements in public health in ...

On Sunday, Feb. 16 at 6 p.m., KETV will air its hour-long documentary, "COVID-19: Life After the Pandemic," which highlights everything from the medical communities' memories of the pandemic, to ...

Use of donepezil (Aricept), an acetylcholinesterase inhibitor, for 3 weeks failed to demonstrate efficacy in treating fatigue and psychological symptoms of long COVID in a randomized trial from Japan.